Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

PURPOSE: To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). PATIENTS AND METHODS: A phase II, open-label, multicenter study was conducted with single-agent clofarabine in pediatric patients with refractory or relapsed A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jeha, Sima, Razzouk, Bassem, Rytting, Michael, Rheingold, Susan, Albano, Edythe, Kadota, Richard, Luchtman-Jones, Lori, Bomgaars, Lisa, Gaynon, Paul, Goldman, Stewart, Ritchey, Kim, Arceci, Robert, Altman, Arnold, Stine, Kimo, Steinherz, Laurel, Steinherz, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744276/
https://ncbi.nlm.nih.gov/pubmed/19652076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.8706
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados